GMO Ultra-Short Income ETF
GMOC
6 hedge funds and large institutions have $29.7M invested in GMO Ultra-Short Income ETF in 2026 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 0 reducing their positions, and 0 closing their positions.
167% more capital invested
Capital invested by funds: $11.1M → $29.7M (+$18.6M)
50% more funds holding
Funds holding: 4 → 6 (+2)
0.07% more ownership
Funds ownership: 74.17% → 74.24% (+0.07%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$16.9M |
| 2 |
Morgan Stanley
New York
|
+$546K |
| 3 |
Jane Street
New York
|
+$501K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$494K |
| 5 |
Goldman Sachs
New York
|
+$145K |
Top Sellers
GMOC Hedge Fund Activity: Q2 2026 in Review
6 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in GMO Ultra-Short Income ETF (GMOC) for Q2 2026, worth a combined $29.7M — up 167% from $11.1M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new GMOC positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 0 trimmed.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), adding an estimated $16.9M.
- 6 institutional investors held GMO Ultra-Short Income ETF (GMOC) as of Q2 2026, up from 4 in Q1 2026.
- Funds reported $29.7M of GMO Ultra-Short Income ETF stock for Q2 2026, up 167% quarter-over-quarter.
- 2 funds opened new GMO Ultra-Short Income ETF positions in Q2 2026 and 0 closed out, a net change of +2 holders.
- The largest GMO Ultra-Short Income ETF buyer in Q2 2026 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $16.9M added.
Based on aggregated 13F filings for Q2 2026.